Nephros (NEPH) EPS (Basic) Growth (3y) (2013 - 2026)
Nephros (NEPH) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 24.18% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 0.16% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 18.97% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.12% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -33.83% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -58.57% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.97% |
| 10 | Nephros | 48.26 Mn | 43.56 Mn | 4.03 Mn | 66.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.58% |
| Mar 31, 2026 | 27.89% |
| Dec 31, 2025 | 27.35% |
| Sep 30, 2025 | 28.08% |
| Jun 30, 2025 | 29.89% |
| Mar 31, 2025 | 24.71% |
| Dec 31, 2024 | 32.27% |
| Sep 30, 2024 | 28.92% |
| Jun 30, 2024 | 38.68% |
| Mar 31, 2024 | 31.01% |
| Dec 31, 2023 | 11.33% |
| Sep 30, 2023 | 47.26% |
| Jun 30, 2023 | 39.63% |
| Mar 31, 2023 | 39.57% |
| Dec 31, 2022 | -48.58% |
| Sep 30, 2022 | -44.29% |
| Jun 30, 2022 | 4.89% |
| Mar 31, 2022 | -0.21% |
| Dec 31, 2021 | -4.74% |
| Sep 30, 2021 | -16.97% |